Our Company2020-06-28T11:59:19-06:00

OUR COMPANY

RARE PHARMA-GRADE BARIUM SULFATE AND IODINE IN NORTH AMERICA

  • Voyageur Pharmaceuticals Ltd. (VM: TSX-V, OTC: VVYRF, Forum) is developing near term cash flow on its 100% owned high grade barium sulfate project in BC, Canada and, is actively exploring and developing Iodine brine projects in the USA.
  • VM business plan is to immediately develop its advanced stage pharmaceutical grade barium sulfate deposit, Frances Creek, and create cash flow. Voyageur is developing barium contrast radiographic suspension products for the pharmaceutical industry.
  • Frances Creek production start up scheduled for May 1st, 2021
  • VM’s pharmaceutical grade barite is naturally occurring with grades as high as 99.26% BaSO4 in-situ, which is very rare.
  • Voyageur has achieved a 98.6% BaSO4 product with SGS Minerals, which is the  highest grade natural occurring barite in the  world. The only barite sold in  the market  place, grading +98%, is man made in a lab using  an expensive manufacturing processing.
  • The only other source of natural pharmaceutical grade barite is from China.
  • China only exports 5% of their production of pharmaceutical barite, allocating 95% for their  domestic market.
  • The pharmaceutical industry is forced to use expensive man made barium sulfate for the  radiographic market.
COMPANY NEWS ARCHIVES